Spencer Jones

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Physical Activity

Respiratory Failure

Top Venues

Clinical pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Amita Datta-Mannan, Arie Regev, David E Coutant, Andrew J Dropsey, Joanne Foster, Spencer Jones, Josh Poorbaugh, Carsten Schmitz, Evan Wang, Michael E Woodman
Safety, Tolerability, and Pharmacokinetics of an Oral Small Molecule Inhibitor of IL-17A (LY3509754): A Phase I Randomized Placebo-Controlled Study. Clinical pharmacology and therapeutics 115 (5) (2024)
Amita Datta-Mannan, Arie Regev, David E Coutant, Andrew J Dropsey, Joanne Foster, Spencer Jones, Josh Poorbaugh, Carsten Schmitz, Evan Wang, Michael E Woodman
Safety, Tolerability, and Pharmacokinetics of an Oral Small Molecule Inhibitor of IL-17A (LY3509754): A Phase I Randomized Placebo-Controlled Study. Clinical pharmacology and therapeutics 115 (5) (2024)
Amita Datta-Mannan, Arie Regev, David E Coutant, Andrew J Dropsey, Joanne Foster, Spencer Jones, Josh Poorbaugh, Carsten Schmitz, Evan Wang, Michael E Woodman
Safety, Tolerability, and Pharmacokinetics of an Oral Small Molecule Inhibitor of IL-17A (LY3509754): A Phase I Randomized Placebo-Controlled Study. Clinical pharmacology and therapeutics (2024)
Amita Datta-Mannan, Arie Regev, David E Coutant, Andrew J Dropsey, Joanne Foster, Spencer Jones, Josh Poorbaugh, Carsten Schmitz, Evan Wang, Michael E Woodman
Safety, Tolerability, and Pharmacokinetics of an Oral Small Molecule Inhibitor of IL-17A (LY3509754): A Phase I Randomized Placebo-Controlled Study. Clinical pharmacology and therapeutics 115 (5) (2024)